Breast milk drug study withdrawn before start

NCT ID NCT06181630

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to measure how much of the drug ozanimod passes into breast milk and to check for any effects on breastfed infants. It planned to include lactating women already taking ozanimod for medical reasons. However, the study was withdrawn before enrolling any participants, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREASTFED INFANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • PPD Las Vegas Clinical Research Unit

    Las Vegas, Nevada, 89113-2228, United States